Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
SOF/VEL/VOX effectief en veilig bij hepatitis C na falen op DAA’s
mrt 2020 | Hepatitis